Disease/Infection News RSS Feed - Disease/Infection News

University of Vermont Medical Center recognized with 2014 Partnership in Prevention Award

University of Vermont Medical Center recognized with 2014 Partnership in Prevention Award

The U.S. Department of Health and Human Services, the Association for Professionals in Infection Control and Epidemiology, and the Society for Healthcare Epidemiology of America today recognized the University of Vermont Medical Center with the 2014 Partnership in Prevention Award for achieving sustainable improvements toward eliminating healthcare-associated infections (HAIs). [More]
UTMB researchers receive awards at American Society of Tropical Medicine and Hygiene meeting

UTMB researchers receive awards at American Society of Tropical Medicine and Hygiene meeting

Scientists at the University of Texas Medical Branch were recognized with prestigious awards for their contributions in research at the annual American Society of Tropical Medicine and Hygiene meeting. [More]
Researchers discover a new way to combat influenza virus infection

Researchers discover a new way to combat influenza virus infection

The influenza virus, like all viruses, is a hijacker. It quietly slips its way inside cells, steals the machinery inside to make more copies of itself, and then -- having multiplied -- bursts out of the cell to find others to infect. [More]
FIRS mobilizes members to raise awareness on COPD

FIRS mobilizes members to raise awareness on COPD

On World COPD Day (19 November 2014), the Forum of International Respiratory Societies (FIRS) is mobilizing its members to raise awareness of the disease and help prevent the risk factors that cause it. [More]
Infections due to Staphylococcus aureus bacterium aggravate neurodermatitis

Infections due to Staphylococcus aureus bacterium aggravate neurodermatitis

Because the skin and its function as a barrier are severely compromised in neurodermatitis patients, a large number of bacterial species are able to multiply - including the bacterium Staphylococcus aureus. [More]
NPS MedicineWise Reducing Antibiotic Resistance program focuses on urinary tract infections

NPS MedicineWise Reducing Antibiotic Resistance program focuses on urinary tract infections

The next phase of the NPS MedicineWise Reducing Antibiotic Resistance program for health professionals has launched today focused on the complex topic of managing urinary tract infections (UTIs). [More]
New research may help develop drug for celiac disease

New research may help develop drug for celiac disease

Celiac disease patients suffer from gluten intolerance and must adjust to a life without gluten from food sources like wheat, rye and barley. [More]
A new method for determining onset of elevated influenza activity at community level

A new method for determining onset of elevated influenza activity at community level

Predicting the beginning of influenza outbreaks is notoriously difficult, and can affect prevention and control efforts. [More]
Avantis Medical Systems' Third Eye Panoramic device for colonoscopy receives FDA clearance

Avantis Medical Systems' Third Eye Panoramic device for colonoscopy receives FDA clearance

Avantis Medical Systems, Inc., a technology leader in developing novel digital imaging devices, today announced that its Third Eye Panoramic device for colonoscopy has received 510(k) clearance from the U.S. Food & Drug Administration (FDA). [More]
Flusurvey to offer self-administered nasal swab to all participants

Flusurvey to offer self-administered nasal swab to all participants

People taking part in this year’s Flusurvey, the UK’s biggest crowd-sourced study of influenza will for the first time be offered a swab to confirm if their symptoms are caused by a flu virus or not as part of a new collaboration with i-sense. Data from social media and internet searches will also be combined with Flusurvey, allowing flu trends to be monitored across the UK more accurately and earlier than ever before. [More]
New method could make Ebola surveillance quicker, cheaper for West African nations

New method could make Ebola surveillance quicker, cheaper for West African nations

A new method for examining the Ebola virus genome could make surveillance quicker and cheaper for West African nations, and help detect new forms of the virus. The detailed procedure is being shared with the research community along with the study paper, which is freely available in the open access journal Genome Biology. [More]
Great Basin Scientific seeks FDA approval for Group B Strep assay

Great Basin Scientific seeks FDA approval for Group B Strep assay

Great Basin Scientific, Inc., a molecular diagnostics company, today announced it has submitted its Group B Strep assay to the U.S. Food and Drug Administration for 510(k) clearance. [More]
'Spillover' of henipaviruses into humans underway, study finds

'Spillover' of henipaviruses into humans underway, study finds

Another family of viruses, deadly in some cases, may have already jumped from fruit bats into humans in Africa, according to a study published today in the journal Nature Communications. The study provides the first, preliminary scientific evidence that "spillover" of henipaviruses into human populations is underway. [More]
TSRI scientists reveal how ZMapp antibodies target Ebola virus

TSRI scientists reveal how ZMapp antibodies target Ebola virus

Scientists at The Scripps Research Institute have identified weak spots on the surface of Ebola virus that are targeted by the antibodies in ZMapp, the experimental drug cocktail administered to several patients during the recent Ebola outbreak. [More]
Scientists call for public to help monitor spread of flu across the UK

Scientists call for public to help monitor spread of flu across the UK

People taking part in this year's Flusurvey, the UK's biggest crowd-sourced study of influenza will for the first time be offered a swab to confirm if their symptoms are caused by a flu virus or not as part of a new collaboration with i-sense. Data from social media and internet searches will also be combined with Flusurvey, allowing flu trends to be monitored across the UK more accurately and earlier than ever before. [More]
Three-day global symposium on Ebola virus, other infectious diseases

Three-day global symposium on Ebola virus, other infectious diseases

The 11th annual International Consortium on Anti-Virals (ICAV) symposium, Infectious Diseases: Global Public-Health Challenges of the Next Decade, will put the challenges posed by several infectious diseases under the microscope, including the Ebola virus, the H7N9 influenza virus, MERS coronavirus and dengue viruses, as well as drug-resistant tuberculosis. [More]
Uber brings on-demand flu prevention to Chicago

Uber brings on-demand flu prevention to Chicago

In partnership with Vaccine Finder, Uber is bringing on-demand flu prevention to Chicago. UberHEALTH helps Chicagoans stay healthy this season with flu prevention packs on demand TODAY, Nov. 18 from 10 am until 4 pm CST for free. [More]

Johns Hopkins Medicine names eight new scholars to improve health care in India

The Center for Clinical Global Health Education at Johns Hopkins Medicine, with significant financial support from the Ujala Foundation and the Wyncote Foundation, has named eight new scholars to improve health care in India, with a particular focus on fighting tuberculosis. [More]
New look at the workings of HIV, other viruses

New look at the workings of HIV, other viruses

UC Davis researchers are getting a new look at the workings of HIV and other viruses thanks to new techniques in electron microscopy developed on campus. [More]
MUHC study examines effect of regular re-evaluation of antibiotic use on cost, C. difficile infection rates

MUHC study examines effect of regular re-evaluation of antibiotic use on cost, C. difficile infection rates

Resistance to antibiotics is an important health concern that affects both the spread of infections, like Clostridium difficile, and the medication budget. Researchers at the McGill University Health Centre examined the effectiveness of adopting an antibiotic "time-out" during treatment, which involves regularly re-evaluating the treatment strategy as the clinical situation evolves. [More]